High prevalence of myeloid neoplasms in adults with non-Langerhans cell histiocytosis.

about

The histopathology of Erdheim-Chester disease: a comprehensive review of a molecularly characterized cohort.JAK2 V617F mutation in plasma cell-free DNA preceding clinically overt myelofibrosis: Implications for early diagnosis.

P2860

Q47563939-EA6BFF0A-F6A4-45CC-B635-0B9625871185 Q52642826-EA981E51-AB81-44B9-BB23-E2DF758C876B

P2860

High prevalence of myeloid neoplasms in adults with non-Langerhans cell histiocytosis.

Item

http://www.wikidata.org/entity/Q38692332

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

High prevalence of myeloid neoplasms in adults with non-Langerhans cell histiocytosis.

@en

type

Item

label

High prevalence of myeloid neoplasms in adults with non-Langerhans cell histiocytosis.

@en

prefLabel

High prevalence of myeloid neoplasms in adults with non-Langerhans cell histiocytosis.

@en

P1476

High prevalence of myeloid neoplasms in adults with non-Langerhans cell histiocytosis

@en

P2093

Ahmet Dogan

http://www.w3.org/2001/XMLSchema#string

Baptiste Hervier

http://www.w3.org/2001/XMLSchema#string

Caroline Besnard

http://www.w3.org/2001/XMLSchema#string

Catherine Settegrana

http://www.w3.org/2001/XMLSchema#string

Eli L Diamond

http://www.w3.org/2001/XMLSchema#string

Fleur Cohen-Aubart

http://www.w3.org/2001/XMLSchema#string

Frédéric Charlotte

http://www.w3.org/2001/XMLSchema#string

Gary A Ulaner

http://www.w3.org/2001/XMLSchema#string

Jean-François Emile

http://www.w3.org/2001/XMLSchema#string

Julien Haroche

http://www.w3.org/2001/XMLSchema#string

P2860

Recurrent BRAF mutations in Langerhans cell histiocytosis

Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations.

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation

Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence

RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF

Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis.

Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis.

P304

1007-1013

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2017-01-761718

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

130

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-07-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28679734

http://www.w3.org/2001/XMLSchema#string

P932

5570678

http://www.w3.org/2001/XMLSchema#string

High prevalence of myeloid neoplasms in adults with non-Langerhans cell histiocytosis.

about

P2860

P2860

High prevalence of myeloid neoplasms in adults with non-Langerhans cell histiocytosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932